|
ATAD5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.05670053105212E-10 |
| Normal-vs-Stage2 |
4.501200E-03 |
| Normal-vs-Stage3 |
2.402500E-04 |
| Normal-vs-Stage4 |
1.430600E-01 |
| Stage1-vs-Stage2 |
2.905200E-01 |
| Stage1-vs-Stage3 |
2.524600E-01 |
| Stage1-vs-Stage4 |
4.565400E-01 |
| Stage2-vs-Stage3 |
9.571400E-01 |
| Stage2-vs-Stage4 |
6.686800E-01 |
| Stage3-vs-Stage4 |
6.462200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.84319226548268E-12 |
| Normal-vs-AfricanAmerican |
1.52397999999554E-05 |
| Normal-vs-Asian |
1.363640E-01 |
| Caucasian-vs-AfricanAmerican |
2.227800E-01 |
| Caucasian-vs-Asian |
6.674200E-01 |
| AfricanAmerican-vs-Asian |
9.105600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.42184050591732E-12 |
| Normal-vs-Female |
1.99940000111809E-08 |
| Male-vs-Female |
8.166500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.410000E-04 |
| Normal-vs-Extreme_Weight |
1.20079999998968E-06 |
| Normal-vs-Obese |
2.18679999997029E-07 |
| Normal-vs-Extreme_Obese |
1.111240E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.949010E-01 |
| Normal_Weight-vs-Obese |
5.797000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.234170E-01 |
| Extreme_Weight-vs-Obese |
1.465730E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.404600E-01 |
| Obese-vs-Extreme_Obese |
2.282100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.897200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.85818027631512E-12 |
| Normal-vs-Age(61-80Yrs) |
9.65199999924948E-08 |
| Normal-vs-Age(81-100Yrs) |
1.081600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.159400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.196810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.121900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.563700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.275500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.813160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.66533453693773E-14 |
| Normal-VS-Type2 PRCC |
7.100800E-03 |
| Normal-VS-KIRP CIMP |
3.789700E-02 |
| Normal-VS-Unclassified PRCC |
4.1481000000454E-06 |
| Type1 PRCC-VS-Type2 PRCC |
2.043600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.498800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.104200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.138020E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.247500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.352600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.98430000000394E-05 |
| Normal-vs-N1 |
2.340200E-03 |
| Normal-vs-N2 |
2.105600E-01 |
| N0-vs-N1 |
2.699800E-02 |
| N0-vs-N2 |
8.070800E-01 |
| N1-vs-N2 |
3.857000E-01 |
|
|
